Samatasvir, CAS 1312547-19-5

Formulation: A solid

Formal Name: N-[(1R)-2-[(2S)-2-[5-[4-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-yl]thieno[3,2-b]thien-3-yl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-carbamic acid, methyl ester

Purity: ≥98%

Formula Markup: C47H48N8O6S2

Formula Weight: 885,1

Shelf life (days): 1460

CAS Number: 1312547-19-5

Notes: Samatasvir is an inhibitor of hepatitis C virus (HCV) non-structural protein 5A (NS5A).{65392} It inhibits HCV replication in stable replicon cell lines containing NS5A from genotypes 1a, -1b, -2a, -3a, -4a, and -5a (EC50s = 2-24 pM). Samatasvir acts additively with the nucleotide prodrug IDX184, NS5B inhibitor TMC647055, or NS3/4A protease inhibitor simeprevir (Item No. 22144) to inhibit viral replication in genotype 1b HCV replicon cells.

• Artikelnummer: CAY36776-5
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 36776-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Methode: Reinstoffe